Spero Therapeutics Other Long Term Liabilities (Quarterly) Trends

Spero Therapeutics, Inc. (SPRO)

2.51 +0.06 (+2.45%) USD | NASDAQ | Jan 14, 13:40

View Other Long Term Liabilities (Quarterly) for SPRO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

BioMarin Pharmaceutical, Inc.	Upgrade
Amicus Therapeutics, Inc.	Upgrade
Cassava Sciences, Inc.	Upgrade
Omeros Corp.	Upgrade
GeoVax Labs, Inc.	--